Inventor
Sharon Avkin-Nachum
Inventor
Nes Ziona, IL
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes25%
C07HSugars5%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
C12YEnzymes2%
PatentTitleYear
10,781,449Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof202010,494,631siRNA compounds comprising terminal substitutions201910,421,962Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof201910,144,928Double stranded oligonucleotide compounds comprising positional modifications201810,093,923Modulation of HSP47 expression201810,059,942Therapeutic oligonucleotides comprising pyrazolotriazine nucleotide analogues20189,932,578Double-stranded oligonucleotide molecules to P53 and methods of use thereof20189,889,200'Sphingolipid-polyalkylamine-oligonucleotide compounds'20189,822,362'Compositions and methods for treating lung disease and injury'20179,796,979'Oligonucleotide modulators of the toll-like receptor pathway'20179,701,960'siRNA compounds comprising terminal substitutions'20179,611,473'Double-stranded nucleic acid compounds'20179,611,474'Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof'20179,487,778'Oligonucleotide modulators of the toll-like receptor pathway'20169,249,414'Oligonucleotide compounds comprising non-nucleotide overhangs'20169,205,100'Compositions and methods for treating lung disease and injury'20159,206,424'Modulation of HSP47 expression'20159,045,755'Double stranded RNA compounds to RhoA and use thereof'20158,859,751'Oligonucleotide compounds comprising non-nucleotide overhangs'20148,796,239'Sirna compounds comprising terminal substitutions'20148,710,209'Modulation of HSP47 expression'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2020Patents assigned to QUARK PHARMACEUTICALS INC (16)· patent assignee history
2014–2016Patents assigned to AVKIN-NACHUM SHARON (6)· patent assignee history
2014–2016Patents assigned to FEINSTEIN ELENA (5)· patent assignee history
2014–2016Patents assigned to KALINSKI HAGAR (4)· patent assignee history
2014–2016Patents assigned to METT IGOR (4)· patent assignee history
2014–2020Based in Nes Ziona, IL· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| QUARK PHARMACEUTICALS INC | 16 | 2014–2020 |
| AVKIN-NACHUM SHARONself | 6 | 2014–2016 |
| FEINSTEIN ELENA | 5 | 2014–2016 |
| KALINSKI HAGAR | 4 | 2014–2016 |
| METT IGOR | 4 | 2014–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Nes Ziona, IL | 21 | 2014–2020 |